Rifamycins can sharply reduce voriconazole exposure, review finds
A structured review found strong clinical evidence that rifamycins can markedly reduce voriconazole exposure, while evidence for most other antituberculosis ...
A structured review found strong clinical evidence that rifamycins can markedly reduce voriconazole exposure, while evidence for most other antituberculosis ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine